Global Medical Aesthetics Market Size, Trends and Forecast to 2024
©
Global Medical Aesthetic Market, By Product Type (Aesthetic Laser Devices, Energy Devices, Skin Tightening and Body Contouring Devices, Aesthetic Implants, Facial Aesthetic Devices), By Applications (Anti Aging and Wrinkles, Facial & Skin Rejuvenation, Vascular Lesions, Body shaping & cellulite, Breast Enhancement, Scars, Pigment Lesions, Reconstructive Surgery, Tattoo Removal, Hair Removal, Psoriasis & Vitilgo, Skin Surgery, Skin Tightening), By End-User (Hospitals , Dermatology Clinics, Cosmetic Centers, Medical Spas & Beauty Center), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Global medical aesthetics market is expected to reach USD 16.1 billion by 2024 from USD 8.33 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-aesthetics-market
The usage of medical aesthetics devices are increasing in today’s market owing to its benefits such as maintaining the youthful appearance ,pain free and non invasive beauty treatments, maintenance free skin that remains smooth and hairless without the need for shaving, waxing or unpleasant hair treatments, improving the cosmetic appearance, technological advancement in medical aesthetics devices.
The Global Medical Aesthetic Devices Market is segmented on the basis of product type, application, end-user, distribution channel and geography.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-medical-aesthetics-market/
On the basis of product type global medical aesthetic devices market is segmented into Aesthetic Laser devices which is further sub divided into Fractional Carbon Dioxide Laser Resurfacing, Ablative Skin Resurfacing Devices, Non-Ablative Fractional Laser Skin Resurfacing ; Energy Devices which is further segmented into Electrocautery, Electrosurgery, Cryosurgery, Laser surgery, Microwave , Harmonic scalpel.
On the basis of application type into anti aging and wrinkles, facial & skin rejuvenation, vascular lesions, body shaping & cellulite, breast enhancement, scars, pigment lesions, reconstructive surgery, tattoo removal, hair removal, psoriasis & vitilgo, skin tightening and others.
On the basis of application the global surgical navigation systems and software market is classified into orthopedic, ENT, neurosurgery dental and others. On the basis of end users the market is segmented into hospitals and ambulatory surgical centres.
On the basis of end users into hospitals , dermatology clinics, cosmetic centers, medical spas & beauty center.
Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa.
The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
The global medical aesthetics market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For example on Feb, 2017 Allergan Plc (AGN) announced that it has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Some of the major players operating in this market are
• Allergan plc
• Neograft Technologies Inc
• BTL Aesthetics
• Galderma S.A.
• Thermi
• Merz Pharma Gmbh & Co
• Surgical Specialties Corporation
• Suneva Medical
• Venus concept
• Valeant Pharmaceuticals International
• Sientra Inc
• Cynosure Inc
• Revance Therapeutics Inc
• Zeltiq Aesthetics Inc
• Dynatronics Corporation
• EternoGen Aesthetics
• GC Aesthetics
• Obagi Skin Health Institute
• Dermatology Associates
• Alma Lasers GmbH
• Cutera Inc
• Ellman International Inc
• Genesis Biosystems Inc
• PhotoMedex Inc, Sciton Inc
• Smith & Nephew Healthcare Pvt. Ltd.
• Solta Medical Corporate
• Syneron Medical Ltd
• Laboratories Vivacy
• Prollenium Medical Technologies
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-aesthetics-market
Table Of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL MEDICAL AESTHETICS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL MEDICAL AESTHETICS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.4. GLOBAL MEDICAL AESTHETICS MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPURTUNITIES
3.4. CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. AESTHETIC LASER DEVICES, BY PRODUCT TYPE
6.2.1. CARBON DIOXIDE LASER RESURFACING
6.2.2. ABLATIVE SKIN RESURFACING DEVICES
6.2.3. NON-ABLATIVE FRACTIONAL LASER SKIN RESURFACING DEVICES
6.3. ENERGY DEVICES, BY PRODUCT TYPE
6.3.1. ELECTROCAUTERY DEVICES
6.3.2. ELECTROSURGERY DEVICES
6.3.3. CRYOSURGERY DEVICES
6.3.4. LASER SURGERY DEVICES
6.3.5. MICROWAVE DEVICES
6.3.6. HARMONIC SCALPEL
6.4. SKIN TIGHTENING AND BODY CONTOURING DEVICES, BY PRODUCT TYPE
6.4.1. LIPOSUCTION DEVICES
6.4.2. SKIN TIGHTENING DEVICES
6.4.3. CELLULITE REDUCTION DEVICES
6.5. AESTHETIC IMPLANTS, BY PRODUCT TYPE
6.5.1. BREAST AUGMENTATION
6.5.2. AESTHETIC DENTAL IMPLANTS
6.5.3 . SOFT TISSUE IMPLANTS
6.5.4. BUTTOCK AUGMENTATION
6.5.5. TRANSDERMAL IMPLANT
6.6. FACIAL AESTHETIC DEVICES, BY PRODUCT TYPE
6.6.1. BOTOX INJECTIONS
6.6.2. CHEMICAL PEELS
6.6.3. COLLAGEN INJECTIONS
6.6.4. COSMETIC ACUPUNCTURE
6.6.5. DERMAL FILLER INJECTIONS
6.6.6. ELECTROTHERAPY
6.6.7. FACIAL TONING
6.6.8. FRAXEL
6.6.9. MICRODERABRASION
6.6.10. PHOTOREJUVENATION
6.6.11. NEUROMODULATORS
6.6.12. PERMANENT MAKEUP
7. GLOBAL MEDICAL AESTHETICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. ANTI AGING AND WRINKLES
7.3. FACIAL & SKIN REJUVENATION
7.4. VASCULAR LESIONS
7.5. BODY SHAPING & CELLULITE
7.6. BREAST ENHANCEMENT
7.7. SCARS, PIGMENT LESIONS, RECONSTRUCTIVE SURGERY
7.8. TATTOO REMOVAL
7.9. PSORIASIS & VITILGO
7.10. SKIN SURGERY
7.11. SKIN TIGHTENING
8. GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
8.1. OVERVIEW
8.2. DERMATOLOGY CLINICS
8.3. HOSPITALS
8.4. COSMETIC CENTERS
8.5. MEDICAL SPAS & BEAUTY CENTER
9. GLOBAL MEDICAL AESTHETICS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE GLOBAL MEDICAL AESTHETICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. GLOBAL MEDICAL AESTHETICS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.5. MEA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.6. SOUTH AMERICA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. GLOBAL MEDICAL AESTHETICS MARKET, COMPANY PROFILES
11.1. ALLERGAN PLC
11.1.1. COMPANY OVERVIEW
11.1.2. FIANCIAL ANALYSIS
11.1.3. PRODUCT MATRIX
11.1.4. RECENT DEVELOPMENTS
11.1.5. DATABRIDGE ANALYSIS
11.2. NEOGRAFT TECHNOLOGIES INC
11.2.1. COMPANY OVERVIEW
11.2.2. FIANCIAL ANALYSIS
11.2.3. PRODUCT MATRIX
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATABRIDGE ANALYSIS
11.3. BTL AESTHETICS
11.3.1. COMPANY OVERVIEW
11.3.2. FIANCIAL ANALYSIS
11.3.3. PRODUCT MATRIX
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATABRIDGE ANALYSIS
11.4. GALDERMA S.A.
11.4.1. COMPANY OVERVIEW
11.4.2. FIANCIAL ANALYSIS
11.4.4. PRODUCT MATRIX
11.4.4. RECENT DEVELOPMENTS
11.4.5. DATABRIDGE ANALYSIS
11.5. THERMI
11.5.1. COMPANY OVERVIEW
11.5.2. FIANCIAL ANALYSIS
11.5.3. PRODUCT MATRIX
11.5.4. RECENT DEVELOPMENTS
11.5.5. DATABRIDGE ANALYSIS
11.6. MERZ PHARMA GMBH & CO
11.6.1. COMPANY OVERVIEW
11.6.2. FIANCIAL ANALYSIS
11.6.3. PRODUCT MATRIX
11.6.4. RECENT DEVELOPMENTS
11.6.5. DATABRIDGE ANALYSIS
11.7. SURGICAL SPECIALTIES CORPORATION
11.7.1. COMPANY OVERVIEW
11.7.2. FIANCIAL ANALYSIS
11.7.3. PRODUCT MATRIX
11.7.4. RECENT DEVELOPMENTS
11.7.5. DATABRIDGE ANALYSIS
11.8. SUNEVA MEDICAL
11.8.1. COMPANY OVERVIEW
11.8.2. FIANCIAL ANALYSIS
11.8.3. PRODUCT MATRIX
11.8.4. RECENT DEVELOPMENTS
11.8.5. DATABRIDGE ANALYSIS
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL
11.9.1. COMPANY OVERVIEW
11.9.2. FIANCIAL ANALYSIS
11.9.3. PRODUCT MATRIX
11.9.4. RECENT DEVELOPMENTS
11.9.5. DATABRIDGE ANALYSIS
11.10. SIENTRA INC
11.10.1. COMPANY OVERVIEW
11.10.2. FIANCIAL ANALYSIS
11.10.3. PRODUCT MATRIX
11.10.4. RECENT DEVELOPMENTS
11.10.5. DATABRIDGE ANALYSIS
11.11. CYNOSURE INC
11.11.1. COMPANY OVERVIEW
11.11.2. FIANCIAL ANALYSIS
11.11.3. PRODUCT MATRIX
11.11.4. RECENT DEVELOPMENTS
11.11.5. DATABRIDGE ANALYSIS
11.12. REVANCE THERAPEUTICS INC
11.12.1. COMPANY OVERVIEW
11.12.2. FIANCIAL ANALYSIS
11.12.3. PRODUCT MATRIX
11.12.4. RECENT DEVELOPMENTS
11.12.5. DATABRIDGE ANALYSIS
11.13. ZELTIQ AESTHETICS INC
11.13.1. COMPANY OVERVIEW
11.13.2. FIANCIAL ANALYSIS
11.13.3. PRODUCT MATRIX
11.13.4. RECENT DEVELOPMENTS
11.13.5. DATABRIDGE ANALYSIS
11.14. DYNATRONICS CORPORATION
11.14.1. COMPANY OVERVIEW
11.14.2. FIANCIAL ANALYSIS
11.14.3. PRODUCT MATRIX
11.14.4. RECENT DEVELOPMENTS
11.14.5. DATABRIDGE ANALYSIS
11.15. ETERNOGEN AESTHETICS
11.15.1. COMPANY OVERVIEW
11.15.2. FIANCIAL ANALYSIS
11.15.3. PRODUCT MATRIX
11.15.4. RECENT DEVELOPMENTS
11.15.5. DATABRIDGE ANALYSIS
11.16. GC AESTHETICS
11.16.1. COMPANY OVERVIEW
11.16.2. FIANCIAL ANALYSIS
11.16.3. PRODUCT MATRIX
11.16.4. RECENT DEVELOPMENTS
11.16.5. DATABRIDGE ANALYSIS
11.17. OBAGI SKIN HEALTH INSTITUTE
11.17.1. COMPANY OVERVIEW
11.17.2. FIANCIAL ANALYSIS
11.17.3. PRODUCT MATRIX
11.17.4. RECENT DEVELOPMENTS
11.17.5. DATABRIDGE ANALYSIS
11.18. DERMATOLOGY ASSOCIATES
11.18.1. COMPANY OVERVIEW
11.18.2. FIANCIAL ANALYSIS
11.18.3. PRODUCT MATRIX
11.18.4. RECENT DEVELOPMENTS
11.18.5. DATABRIDGE ANALYSIS
11.19. ALMA LASERS GMBH
11.19.1. COMPANY OVERVIEW
11.19.2. FIANCIAL ANALYSIS
11.19.3. PRODUCT MATRIX
11.19.4. RECENT DEVELOPMENTS
11.19.5. DATABRIDGE ANALYSIS
11.20. CUTERA INC
11.20.1. COMPANY OVERVIEW
11.20.2. FIANCIAL ANALYSIS
11.20.3. PRODUCT MATRIX
11.20.4. RECENT DEVELOPMENTS
11.20.5. DATABRIDGE ANALYSIS
11.21. CYNOSURE INC
11.21.1. COMPANY OVERVIEW
11.21.2. FIANCIAL ANALYSIS
11.21.3. PRODUCT MATRIX
11.21.4. RECENT DEVELOPMENTS
11.21.5. DATABRIDGE ANALYSIS
11.22. ELLMAN INTERNATIONAL INC
11.22.1. COMPANY OVERVIEW
11.22.2. FIANCIAL ANALYSIS
11.22.3. PRODUCT MATRIX
11.22.4. RECENT DEVELOPMENTS
11.22.5. DATABRIDGE ANALYSIS
11.23. PHOTOMEDEX INC
11.23.1. COMPANY OVERVIEW
11.23.2. FIANCIAL ANALYSIS
11.23.3. PRODUCT MATRIX
11.23.4. RECENT DEVELOPMENTS
11.23.5. DATABRIDGE ANALYSIS
11.24. SMITH AND NEPHEW
11.24.1. COMPANY OVERVIEW
11.24.2. FIANCIAL ANALYSIS
11.24.3. PRODUCT MATRIX
11.24.4. RECENT DEVELOPMENTS
11.24.5. DATABRIDGE ANALYSIS
11.25. SOLTA MEDICAL CORPORATE
11.25.1. COMPANY OVERVIEW
11.25.2. FIANCIAL ANALYSIS
11.25.3. PRODUCT MATRIX
11.25.4. RECENT DEVELOPMENTS
11.25.5. DATABRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
North America Topical Use Acne Treatment Market – Industry Trends and Forecast to 2024
North America Topical Use Acne Treatment Market, By Product Type, By End-User, By Distribution Channel, By Geography (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/north-america-topical-use-acne-treatment-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Global medical aesthetics market is expected to reach USD 16.1 billion by 2024 from USD 8.33 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-aesthetics-market
The usage of medical aesthetics devices are increasing in today’s market owing to its benefits such as maintaining the youthful appearance ,pain free and non invasive beauty treatments, maintenance free skin that remains smooth and hairless without the need for shaving, waxing or unpleasant hair treatments, improving the cosmetic appearance, technological advancement in medical aesthetics devices.
The Global Medical Aesthetic Devices Market is segmented on the basis of product type, application, end-user, distribution channel and geography.
Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-medical-aesthetics-market/
On the basis of product type global medical aesthetic devices market is segmented into Aesthetic Laser devices which is further sub divided into Fractional Carbon Dioxide Laser Resurfacing, Ablative Skin Resurfacing Devices, Non-Ablative Fractional Laser Skin Resurfacing ; Energy Devices which is further segmented into Electrocautery, Electrosurgery, Cryosurgery, Laser surgery, Microwave , Harmonic scalpel.
On the basis of application type into anti aging and wrinkles, facial & skin rejuvenation, vascular lesions, body shaping & cellulite, breast enhancement, scars, pigment lesions, reconstructive surgery, tattoo removal, hair removal, psoriasis & vitilgo, skin tightening and others.
On the basis of application the global surgical navigation systems and software market is classified into orthopedic, ENT, neurosurgery dental and others. On the basis of end users the market is segmented into hospitals and ambulatory surgical centres.
On the basis of end users into hospitals , dermatology clinics, cosmetic centers, medical spas & beauty center.
Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa.
The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
The global medical aesthetics market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For example on Feb, 2017 Allergan Plc (AGN) announced that it has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Some of the major players operating in this market are
• Allergan plc
• Neograft Technologies Inc
• BTL Aesthetics
• Galderma S.A.
• Thermi
• Merz Pharma Gmbh & Co
• Surgical Specialties Corporation
• Suneva Medical
• Venus concept
• Valeant Pharmaceuticals International
• Sientra Inc
• Cynosure Inc
• Revance Therapeutics Inc
• Zeltiq Aesthetics Inc
• Dynatronics Corporation
• EternoGen Aesthetics
• GC Aesthetics
• Obagi Skin Health Institute
• Dermatology Associates
• Alma Lasers GmbH
• Cutera Inc
• Ellman International Inc
• Genesis Biosystems Inc
• PhotoMedex Inc, Sciton Inc
• Smith & Nephew Healthcare Pvt. Ltd.
• Solta Medical Corporate
• Syneron Medical Ltd
• Laboratories Vivacy
• Prollenium Medical Technologies
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-aesthetics-market
Table Of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL MEDICAL AESTHETICS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL MEDICAL AESTHETICS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.4. GLOBAL MEDICAL AESTHETICS MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPURTUNITIES
3.4. CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. AESTHETIC LASER DEVICES, BY PRODUCT TYPE
6.2.1. CARBON DIOXIDE LASER RESURFACING
6.2.2. ABLATIVE SKIN RESURFACING DEVICES
6.2.3. NON-ABLATIVE FRACTIONAL LASER SKIN RESURFACING DEVICES
6.3. ENERGY DEVICES, BY PRODUCT TYPE
6.3.1. ELECTROCAUTERY DEVICES
6.3.2. ELECTROSURGERY DEVICES
6.3.3. CRYOSURGERY DEVICES
6.3.4. LASER SURGERY DEVICES
6.3.5. MICROWAVE DEVICES
6.3.6. HARMONIC SCALPEL
6.4. SKIN TIGHTENING AND BODY CONTOURING DEVICES, BY PRODUCT TYPE
6.4.1. LIPOSUCTION DEVICES
6.4.2. SKIN TIGHTENING DEVICES
6.4.3. CELLULITE REDUCTION DEVICES
6.5. AESTHETIC IMPLANTS, BY PRODUCT TYPE
6.5.1. BREAST AUGMENTATION
6.5.2. AESTHETIC DENTAL IMPLANTS
6.5.3 . SOFT TISSUE IMPLANTS
6.5.4. BUTTOCK AUGMENTATION
6.5.5. TRANSDERMAL IMPLANT
6.6. FACIAL AESTHETIC DEVICES, BY PRODUCT TYPE
6.6.1. BOTOX INJECTIONS
6.6.2. CHEMICAL PEELS
6.6.3. COLLAGEN INJECTIONS
6.6.4. COSMETIC ACUPUNCTURE
6.6.5. DERMAL FILLER INJECTIONS
6.6.6. ELECTROTHERAPY
6.6.7. FACIAL TONING
6.6.8. FRAXEL
6.6.9. MICRODERABRASION
6.6.10. PHOTOREJUVENATION
6.6.11. NEUROMODULATORS
6.6.12. PERMANENT MAKEUP
7. GLOBAL MEDICAL AESTHETICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. ANTI AGING AND WRINKLES
7.3. FACIAL & SKIN REJUVENATION
7.4. VASCULAR LESIONS
7.5. BODY SHAPING & CELLULITE
7.6. BREAST ENHANCEMENT
7.7. SCARS, PIGMENT LESIONS, RECONSTRUCTIVE SURGERY
7.8. TATTOO REMOVAL
7.9. PSORIASIS & VITILGO
7.10. SKIN SURGERY
7.11. SKIN TIGHTENING
8. GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
8.1. OVERVIEW
8.2. DERMATOLOGY CLINICS
8.3. HOSPITALS
8.4. COSMETIC CENTERS
8.5. MEDICAL SPAS & BEAUTY CENTER
9. GLOBAL MEDICAL AESTHETICS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE GLOBAL MEDICAL AESTHETICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. GLOBAL MEDICAL AESTHETICS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.5. MEA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.6. SOUTH AMERICA MEDICAL AESTHETICS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. GLOBAL MEDICAL AESTHETICS MARKET, COMPANY PROFILES
11.1. ALLERGAN PLC
11.1.1. COMPANY OVERVIEW
11.1.2. FIANCIAL ANALYSIS
11.1.3. PRODUCT MATRIX
11.1.4. RECENT DEVELOPMENTS
11.1.5. DATABRIDGE ANALYSIS
11.2. NEOGRAFT TECHNOLOGIES INC
11.2.1. COMPANY OVERVIEW
11.2.2. FIANCIAL ANALYSIS
11.2.3. PRODUCT MATRIX
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATABRIDGE ANALYSIS
11.3. BTL AESTHETICS
11.3.1. COMPANY OVERVIEW
11.3.2. FIANCIAL ANALYSIS
11.3.3. PRODUCT MATRIX
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATABRIDGE ANALYSIS
11.4. GALDERMA S.A.
11.4.1. COMPANY OVERVIEW
11.4.2. FIANCIAL ANALYSIS
11.4.4. PRODUCT MATRIX
11.4.4. RECENT DEVELOPMENTS
11.4.5. DATABRIDGE ANALYSIS
11.5. THERMI
11.5.1. COMPANY OVERVIEW
11.5.2. FIANCIAL ANALYSIS
11.5.3. PRODUCT MATRIX
11.5.4. RECENT DEVELOPMENTS
11.5.5. DATABRIDGE ANALYSIS
11.6. MERZ PHARMA GMBH & CO
11.6.1. COMPANY OVERVIEW
11.6.2. FIANCIAL ANALYSIS
11.6.3. PRODUCT MATRIX
11.6.4. RECENT DEVELOPMENTS
11.6.5. DATABRIDGE ANALYSIS
11.7. SURGICAL SPECIALTIES CORPORATION
11.7.1. COMPANY OVERVIEW
11.7.2. FIANCIAL ANALYSIS
11.7.3. PRODUCT MATRIX
11.7.4. RECENT DEVELOPMENTS
11.7.5. DATABRIDGE ANALYSIS
11.8. SUNEVA MEDICAL
11.8.1. COMPANY OVERVIEW
11.8.2. FIANCIAL ANALYSIS
11.8.3. PRODUCT MATRIX
11.8.4. RECENT DEVELOPMENTS
11.8.5. DATABRIDGE ANALYSIS
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL
11.9.1. COMPANY OVERVIEW
11.9.2. FIANCIAL ANALYSIS
11.9.3. PRODUCT MATRIX
11.9.4. RECENT DEVELOPMENTS
11.9.5. DATABRIDGE ANALYSIS
11.10. SIENTRA INC
11.10.1. COMPANY OVERVIEW
11.10.2. FIANCIAL ANALYSIS
11.10.3. PRODUCT MATRIX
11.10.4. RECENT DEVELOPMENTS
11.10.5. DATABRIDGE ANALYSIS
11.11. CYNOSURE INC
11.11.1. COMPANY OVERVIEW
11.11.2. FIANCIAL ANALYSIS
11.11.3. PRODUCT MATRIX
11.11.4. RECENT DEVELOPMENTS
11.11.5. DATABRIDGE ANALYSIS
11.12. REVANCE THERAPEUTICS INC
11.12.1. COMPANY OVERVIEW
11.12.2. FIANCIAL ANALYSIS
11.12.3. PRODUCT MATRIX
11.12.4. RECENT DEVELOPMENTS
11.12.5. DATABRIDGE ANALYSIS
11.13. ZELTIQ AESTHETICS INC
11.13.1. COMPANY OVERVIEW
11.13.2. FIANCIAL ANALYSIS
11.13.3. PRODUCT MATRIX
11.13.4. RECENT DEVELOPMENTS
11.13.5. DATABRIDGE ANALYSIS
11.14. DYNATRONICS CORPORATION
11.14.1. COMPANY OVERVIEW
11.14.2. FIANCIAL ANALYSIS
11.14.3. PRODUCT MATRIX
11.14.4. RECENT DEVELOPMENTS
11.14.5. DATABRIDGE ANALYSIS
11.15. ETERNOGEN AESTHETICS
11.15.1. COMPANY OVERVIEW
11.15.2. FIANCIAL ANALYSIS
11.15.3. PRODUCT MATRIX
11.15.4. RECENT DEVELOPMENTS
11.15.5. DATABRIDGE ANALYSIS
11.16. GC AESTHETICS
11.16.1. COMPANY OVERVIEW
11.16.2. FIANCIAL ANALYSIS
11.16.3. PRODUCT MATRIX
11.16.4. RECENT DEVELOPMENTS
11.16.5. DATABRIDGE ANALYSIS
11.17. OBAGI SKIN HEALTH INSTITUTE
11.17.1. COMPANY OVERVIEW
11.17.2. FIANCIAL ANALYSIS
11.17.3. PRODUCT MATRIX
11.17.4. RECENT DEVELOPMENTS
11.17.5. DATABRIDGE ANALYSIS
11.18. DERMATOLOGY ASSOCIATES
11.18.1. COMPANY OVERVIEW
11.18.2. FIANCIAL ANALYSIS
11.18.3. PRODUCT MATRIX
11.18.4. RECENT DEVELOPMENTS
11.18.5. DATABRIDGE ANALYSIS
11.19. ALMA LASERS GMBH
11.19.1. COMPANY OVERVIEW
11.19.2. FIANCIAL ANALYSIS
11.19.3. PRODUCT MATRIX
11.19.4. RECENT DEVELOPMENTS
11.19.5. DATABRIDGE ANALYSIS
11.20. CUTERA INC
11.20.1. COMPANY OVERVIEW
11.20.2. FIANCIAL ANALYSIS
11.20.3. PRODUCT MATRIX
11.20.4. RECENT DEVELOPMENTS
11.20.5. DATABRIDGE ANALYSIS
11.21. CYNOSURE INC
11.21.1. COMPANY OVERVIEW
11.21.2. FIANCIAL ANALYSIS
11.21.3. PRODUCT MATRIX
11.21.4. RECENT DEVELOPMENTS
11.21.5. DATABRIDGE ANALYSIS
11.22. ELLMAN INTERNATIONAL INC
11.22.1. COMPANY OVERVIEW
11.22.2. FIANCIAL ANALYSIS
11.22.3. PRODUCT MATRIX
11.22.4. RECENT DEVELOPMENTS
11.22.5. DATABRIDGE ANALYSIS
11.23. PHOTOMEDEX INC
11.23.1. COMPANY OVERVIEW
11.23.2. FIANCIAL ANALYSIS
11.23.3. PRODUCT MATRIX
11.23.4. RECENT DEVELOPMENTS
11.23.5. DATABRIDGE ANALYSIS
11.24. SMITH AND NEPHEW
11.24.1. COMPANY OVERVIEW
11.24.2. FIANCIAL ANALYSIS
11.24.3. PRODUCT MATRIX
11.24.4. RECENT DEVELOPMENTS
11.24.5. DATABRIDGE ANALYSIS
11.25. SOLTA MEDICAL CORPORATE
11.25.1. COMPANY OVERVIEW
11.25.2. FIANCIAL ANALYSIS
11.25.3. PRODUCT MATRIX
11.25.4. RECENT DEVELOPMENTS
11.25.5. DATABRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
North America Topical Use Acne Treatment Market – Industry Trends and Forecast to 2024
North America Topical Use Acne Treatment Market, By Product Type, By End-User, By Distribution Channel, By Geography (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/north-america-topical-use-acne-treatment-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/